1. Home
  2. ATCH vs PDSB Comparison

ATCH vs PDSB Comparison

Compare ATCH & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.20

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.59

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
PDSB
Founded
2022
2005
Country
United States
United States
Employees
N/A
10
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
29.6M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
ATCH
PDSB
Price
$0.20
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
1.4M
413.5K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.51
52 Week High
$1.92
$1.90

Technical Indicators

Market Signals
Indicator
ATCH
PDSB
Relative Strength Index (RSI) 45.08 45.48
Support Level $0.18 $0.52
Resistance Level $0.21 $1.16
Average True Range (ATR) 0.01 0.07
MACD 0.00 0.00
Stochastic Oscillator 70.38 41.10

Price Performance

Historical Comparison
ATCH
PDSB

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: